QuickSwitch™ Class II Tetramer Peptide Exchange and Quantitation Kit utilises a patented technique for exchanging up to ten peptides on an MHC Class II Tetramer.
Cancer Immunotherapy: An increasing emphasis on CD4+ T cells and MHC Class II Neoantigens
